March 2024
1. SUH YS, Lee J, George J, Seol D, et al
   RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation.
   Br J Cancer. 2024 Mar 11. doi: 10.1038/s41416-024-02642.
   

   >> Share

   
   February 2024
2. SAITO T, Kurokawa Y, Fujitani K, Kawabata R, et al
   Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
   Br J Cancer. 2024 Feb 7. doi: 10.1038/s41416-023-02540.
   

   >> Share

   
   
3. CECCHINI M, Cleary JM, Shyr Y, Chao J, et al
   NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
   Br J Cancer. 2024;130:476-482.
   

   >> Share

   
   
4. GROSSER B, Emmerson J, Reitsam NG, Cunningham D, et al
   Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
   Br J Cancer. 2024;130:457-466.
   

   >> Share

   
   January 2024
5. WANG J, Sun N, Kunzke T, Shen J, et al
   Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.
   Br J Cancer. 2024 Jan 24. doi: 10.1038/s41416-023-02559.
   

   >> Share

   
   
6. CAI F, Yang X, Ma G, Wang P, et al
   EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-kappaB signalling activation independent of hydroxylase activity.
   Br J Cancer. 2024 Jan 6. doi: 10.1038/s41416-023-02546.
   

   >> Share

   
   December 2023
7. KAMIYA H, Komatsu S, Takashima Y, Ishida R, et al
   Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
   Br J Cancer. 2023 Dec 26. doi: 10.1038/s41416-023-02532.
   

   >> Share

   
   November 2023
8. ALLAN Z, Witts S, Tie J, Tebbutt N, et al
   The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
   Br J Cancer. 2023;129:1717-1726.
   

   >> Share

   
   August 2023
9. CHEN T, Li D, Wang Y, Shen X, et al
   Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1alpha-FBLN5 signaling pathway.
   Br J Cancer. 2023 Aug 29. doi: 10.1038/s41416-023-02409.
   

   >> Share

   
   
10. ANDO K, Nakamura Y, Kitao H, Shimokawa M, et al
    Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
    Br J Cancer. 2023 Aug 2. doi: 10.1038/s41416-023-02378.
    

    >> Share

    
    July 2023
11. LIU X, Lv K, Wang J, Lin C, et al
    C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02336.
    

    >> Share

    
    
12. LEE JE, Kim KT, Shin SJ, Cheong JH, et al
    Genomic and evolutionary characteristics of metastatic gastric cancer by routes.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02338.
    

    >> Share

    
    June 2023
13. DONG X, Fan J, Xie W, Wu X, et al
    Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.
    Br J Cancer. 2023 Jun 29. doi: 10.1038/s41416-023-02319.
    

    >> Share

    
    April 2023
14. LIU DHW, Kim YW, Sefcovicova N, Laye JP, et al
    Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
    Br J Cancer. 2023 Apr 7. doi: 10.1038/s41416-023-02257.
    

    >> Share

    
    
15. LAAKSONEN MA, Li S, Canfell K, MacInnis RJ, et al
    The future burden of oesophageal and stomach cancers attributable to modifiable behaviours in Australia: a pooled cohort study.
    Br J Cancer. 2023;128:1052-1069.
    

    >> Share

    
    February 2023
16. STARLING N, Cunningham D
    Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhonen, T Kuitunen, P Nyandoto & M Kouri.
    Br J Cancer. 2023 Feb 16. doi: 10.1038/s41416-023-02146.
    

    >> Share

    
    January 2023
17. NI T, Chu Z, Tao L, Zhao Y, et al
    PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.
    Br J Cancer. 2023 Jan 12. doi: 10.1038/s41416-022-02118.
    

    >> Share

    
    
18. OKUNO K, Watanabe S, Roy S, Kanda M, et al
    A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Br J Cancer. 2023 Jan 11. doi: 10.1038/s41416-022-02138.
    

    >> Share

    
    November 2022
19. KOCK AM BRINK M, Dunst LS, Behrens HM, Kruger S, et al
    Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma.
    Br J Cancer. 2022 Nov 8. pii: 10.1038/s41416-022-02047.
    

    >> Share

    
    August 2022
20. YU K, Gu Y, Zhang P, Fang H, et al
    Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer.
    Br J Cancer. 2022 Aug 24. pii: 10.1038/s41416-022-01939.
    

    >> Share

    
    
21. CUI K, Yao S, Liu B, Sun S, et al
    A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer.
    Br J Cancer. 2022 Aug 8. pii: 10.1038/s41416-022-01936.
    

    >> Share

    
    June 2022
22. RABBANI S, Santoni G, Lagergren J, Xie SH, et al
    Use of anti-androgenic 5alpha-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01872.
    

    >> Share

    
    May 2022
23. YAO X, He Z, Qin C, Zhang P, et al
    Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01834.
    

    >> Share

    
    
24. ZANG WJ, Hu YL, Qian CY, Feng Y, et al
    HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01805.
    

    >> Share

    
    
25. ALICANDRO G, Bertuccio P, Collatuzzo G, Pelucchi C, et al
    The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 May 27. pii: 10.1038/s41416-022-01857.
    

    >> Share

    
    
26. MARTIMIANAKI G, Alicandro G, Pelucchi C, Bonzi R, et al
    Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium.
    Br J Cancer. 2022 May 24. pii: 10.1038/s41416-022-01856.
    

    >> Share

    
    February 2022
27. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Correction: Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01761.
    

    >> Share

    
    
28. DALMARTELLO M, Turati F, Zhang ZF, Lunet N, et al
    Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01750.
    

    >> Share

    
    
29. LI Y, Liu C, Zhang X, Huang X, et al
    CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/beta-catenin signalling pathway.
    Br J Cancer. 2022 Feb 22. pii: 10.1038/s41416-022-01747.
    

    >> Share

    
    January 2022
30. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Jan 13. pii: 10.1038/s41416-021-01693.
    

    >> Share

    
    December 2021
31. ADIB E, El Zarif T, Nassar AH, Akl EW, et al
    CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Br J Cancer. 2021 Dec 23. pii: 10.1038/s41416-021-01673.
    

    >> Share

    
    November 2021
32. CHEN K, Gu Y, Cao Y, Fang H, et al
    TIM3(+) cells in gastric cancer: clinical correlates and association with immune context.
    Br J Cancer. 2021 Nov 1. pii: 10.1038/s41416-021-01607.
    

    >> Share

    
    October 2021
33. SHIMURA T, Kandimalla R, Okugawa Y, Ohi M, et al
    Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer.
    Br J Cancer. 2021 Oct 21. pii: 10.1038/s41416-021-01581.
    

    >> Share

    
    
34. KOHLRUSS M, Krenauer M, Grosser B, Pfarr N, et al
    Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01587.
    

    >> Share

    
    
35. BAXTER MA, Middleton F, Cagney HP, Petty RD, et al
    Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.
    Br J Cancer. 2021;125:1068-1079.
    

    >> Share

    
    July 2021
36. ZHENG J, Santoni G, Xie SH, Lagergren J, et al
    Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
    Br J Cancer. 2021;125:277-283.
    

    >> Share

    
    June 2021
37. LEE IS, Ahn J, Kim K, Okugawa Y, et al
    A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Br J Cancer. 2021 Jun 23. pii: 10.1038/s41416-021-01461.
    

    >> Share

    
    April 2021
38. TANAKA H, Kanda M, Miwa T, Umeda S, et al
    G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01366.
    

    >> Share

    
    March 2021
39. TAKASHIMA T, Taniyama D, Sakamoto N, Yasumoto M, et al
    Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
    Br J Cancer. 2021 Mar 30. pii: 10.1038/s41416-021-01364.
    

    >> Share

    
    
40. LI Z, Wu X, Gao X, Shan F, et al
    Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma.
    Br J Cancer. 2021;124:942-950.
    

    >> Share

    
    February 2021
41. MIWA T, Kanda M, Shimizu D, Umeda S, et al
    Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
    Br J Cancer. 2021 Feb 3. pii: 10.1038/s41416-021-01271.
    

    >> Share

    
    October 2020
42. SAITO R, Shoda K, Maruyama S, Yamamoto A, et al
    Platelets enhance malignant behaviours of gastric cancer cells via direct contacts.
    Br J Cancer. 2020 Oct 28. pii: 10.1038/s41416-020-01134.
    

    >> Share

    
    
43. YAMASHITA K, Iwatsuki M, Yasuda-Yoshihara N, Morinaga T, et al
    Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
    Br J Cancer. 2020 Oct 26. pii: 10.1038/s41416-020-01138.
    

    >> Share

    
    
44. OPENSHAW MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, et al
    Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
    Br J Cancer. 2020;123:1271-1279.
    

    >> Share

    
    September 2020
45. ZHAO J, Fu X, Chen H, Min L, et al
    G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.
    Br J Cancer. 2020 Sep 29. pii: 10.1038/s41416-020-01067.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share